Video

Stephen Nuckolls Outlines His Greatest Challenges and Opportunities of the Proposed MSSP Changes

The proposed risk adjustment changes to the Medicare Shared Savings Program (MSSP) are welcome but moving accountable care organizations (ACOs) to risk too soon could harm the program, said Stephen Nuckolls, CEO of Coastal Carolina Quality Care.

The proposed risk adjustment changes to the Medicare Shared Savings Program (MSSP) are welcome but moving accountable care organizations (ACOs) to risk too soon could harm the program, said Stephen Nuckolls, CEO of Coastal Carolina Quality Care.

Transcript

What do you view as the greatest opportunity presented by the proposed MSSP changes? What is the greatest challenge?

I think the greatest opportunity with the new changes may be the risk adjustment; getting a positive upward adjustment really would have helped us in our first contract period. I think that is a positive for this. Also, some of the regional adjustments are also a positive for many ACOs or most ACOs.

On the negative side, making groups move to risk sooner is going to harm the program and that fewer people are going to join or you will have more dropout and the evidence has shown that when ACOs stay in longer and we have more ACOs, that the trust fund is going to save more money. I think that’s really where we need to focus on the program. Not how much savings are achieved based on the benchmark, but how much of the true savings are we achieving for the trust fund?

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo